MRKR

1.09017.42%
ND

Norman David Eansor

Independent Chairman

Mr. Norman David Eansor, also known as Dave, served as the President of Protein Sciences Segment at Bio-Techne Corporation since April 2018 until January 03, 2022. Mr. Eansor served as Senior Vice President of Biotechnology Division at Bio-Techne Corporation from April 2015 to July 1, 2018. Mr. Eansor has been Independent Chairman of Marker Therapeutics, Inc. since May 24, 2022 and has been its Independent Director since October 17, 2018. Mr. Eansor served as President of Bioproducts Business at Cambrex Corporation since 2002. Mr. Eansor served as Senior Vice President of Novus Biologicals of Bio-Techne Corp. since July 2, 2014 until April 2018. Mr. Eansor served as the Senior Vice President of Corporate Development at Novus Biologicals, LLC since January 2013 until July 2, 2014. He has experience in senior positions in the Life Science Industry including President of the Bioscience Division at Thermo Fisher Scientific as well as President of Cambrex Bioproducts. He was President of the Life Science Research business at Thermo Fisher for few years and was also its Division President since early 2010 Mr. Eansor has a B.Sc. in Chemistry from University of Western Ontario, a Bachelors of Commerce in General Business and Economics and an MBA from the University of Windsor, Ontario, Canada.

Positions